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LETTER TO THE EDITOR
Sir,
I read the article by Sun et al “A Prospective
Study of Hepatitis During Antituberculous Treat-
ment in Taiwanese Patients and a Review of the
Literature”,1 that was published in a recent issue
of Journal of the Formosan Medical Association. I
would like to comment on this article.
First, the authors did not discuss whether there
was any difference in the incidence of hepatitis
in patients with pulmonary and extrapulmonary
tuberculosis (TB). Their data suggested that 33 of
227 patients in the pulmonary TB group devel-
oped hepatitis, which corresponded to around
14.5%, whereas in the extrapulmonary TB group,
26.5% (9/34) of the patients developed that
complication. Second, there was no clear indica-
tion as to whether all the patients were receiving
daily or alternate-day treatment, because dose
variation can cause increased incidence or sever-
ity of hepatitis.2 Third, their treatment regimen
suggested that only new cases of TB were included
and no re-treated cases were included. Fourth, it
was not clear if there was any association between
increased incidence of hepatitis and increased
severity of TB or with multiorgan involvement,
because extensive disease is a possible risk factor
for the development of hepatotoxicity.3
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